Cardiovascular and cerebrovascular genetic testing can detect the probability of cardiovascular and cerebrovascular diseases, only in Prevention is not cure. Genetic testing mostly refers to the sensitivity of patients to the effects of various lipid-lowering drugs, antiplatelet drugs, and antihypertensive drugs, as well as the risk of patients suffering from cardiovascular and cerebrovascular diseases. After the patient undergoes genetic testing, the relevant drug treatment can be adjusted according to the genotype, and the sensitive group can be determined according to the genotype, and the sensitive drug can be selected. After adjusting the treatment, the risk of cardiovascular and cerebrovascular diseases can be minimized. Genetic testing can also diagnose diseases. Disease diagnosis is to use genetic testing technology to detect mutated genes that cause hereditary diseases. Currently, it is widely used in the detection of neonatal genetic diseases, the diagnosis of genetic diseases, and the auxiliary diagnosis of certain common diseases. >Early detection of disease risk, early prevention or effective interventions.
Analyze the risk of cardiovascular and cerebrovascular disease, personalized guidance on preventive measures and diet< /strong>, comprehensively protect the physical and mental health of middle-aged and elderly people.
Circulation
CTVR-001
Hypertension
CTVR-005
Myocardial infarction
CTVR-011
Rheumatological Heart Disease
CTVR-013
Venous thrombosis
CTVR-015
Hyperlipidemia
CTVR-018
Arrhythmia
CTVR-019
Cardiac collapse
CTVR-022
Coronary Heart Disease
CTVR-025
Chronic Heart Failure
CTVR-029
QT prolongation syndrome
Phone: 400-099-1215
Company address: Tide Valley Biomedical Industrial Park, Xinxing Park, Gu'an County, Langfang City, Hebei Province
Enterprise Email: boya@newcby.com
New Century Elite Life Technology (Hebei) Co., Ltd. Copyright(C)2021 Ji ICP preparation ******* No.-1